Skip to main content
Caplight Logo









Spiderwort

Spiderwort

Private
OttawaHealthcare & Life Scienceshttps://spiderwortbio.com/

Last Round

Series A

Jul 12, 2022

Total Funding Raised

$16.47M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Spiderwort is a biotechnology company that develops transformative, plant-based biomaterials for tissue repair and regeneration.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, Clinical Trials, Fashion & Beauty

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

biomaterial scaffoldsregenerative medicinetissue engineeringmedical devicescellulose-based biomaterialsbiotechspinal cord injury repairdermal fillersoft tissue augmentationbiocompatible materialsmedical aestheticsbio-scaffoldingclinical-stage biotechimplantable devicesbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spiderwort Comparables

Compare Spiderwort with similar companies based on industry and business-model similarity.

Spiderwort comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LifeSprout
81%
BellaSeno
78%
BE Therapeutics
77%

Spiderwort Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 12, 2022
SeedJun 1, 2020
AngelJun 10, 2019

Key People

Founding team and executive leadership

Andrew Pelling

Co-Founder And Chief Scientific Officer

Founding Team

Charles M. Cuerrier

CEO And Co-Founder

Founding Team

Spiderwort Investors

Notable investors and investment history

Spiderwort investors
InvestorRounds
Horizons VenturesSeries A, Seed
Capital Angel NetworkAngel, Series A, Seed
Break Off CapitalSeries A, Seed
K5 GlobalSeries A
Anges QuebecSeries A, Seed
BoxOne VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 31% MoM, reaching 2.3K.

  • Jul 12, 2022

    $13M round led by Horizons Ventures.

Spiderwort Filings

Explore SEC and related filing metadata, where available.

Spiderwort filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spiderwort's valuation, stock price, and market status.

Is Spiderwort a public or private company?

Spiderwort is a private company.

What is the current stock price of Spiderwort?

Spiderwort is a private company with no public stock price. No recent secondary market data is available.

How much is Spiderwort worth (valuation)?

Valuation information for Spiderwort is not publicly available.

Can I buy Spiderwort stock?

Spiderwort shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spiderwort's last funding round?

Spiderwort's most recent funding round was Series A on July 12, 2022.

Who are the main investors in Spiderwort?

Key investors in Spiderwort include Horizons Ventures.

Will Spiderwort IPO soon?

No public IPO plans have been announced for Spiderwort.

How can I track Spiderwort secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spiderwort's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOttawa
Employee Range15
Year Founded2015
Last FundingJul 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?